3 Live Notices for SAARC Hiv Aids Medicine Tenders
Showing 1 to 3
Supply of Medicine and Medical / Surgical equipments : Human Immunoglobulin for Intravenous use 1g\nvial\nNormal immunoglobulin for intravenous use BP,1g\nVial.\nEach vial to contain 1g of liquid or freeze-dried\npreparation of Normal Immunoglobulin BP for\nintravenous use.\nThe immunoglobulin should be mainly\nimmunoglobulin IgG and contain only trace\namount of IgA.\nNote:\n1.This product should be stable for 02 years when\nstored under storage condition stipulated by the\nmanufacturer.\n2.Tenderers should submit detail specification of\nthe product offered by them.\n3.The product should ensure, at least two steps of\nvirus inactivation as\nrecommended by WHO.\n4.The product should be certified as free from HIV\nand hepatitis virus.\n5.Each vial should be labelled accordingly. etc .
26 Nov 2024
07 Jan 2025Supply of Medicine and Medical / Surgical equipments : Antitetanus Human Immunoglobulin 250IU\nAmpoule/Vial/Prefilled syringe\nAntitetanus Human Immunoglobulin 250IU\nAmpoule/Vial/Prefilled syringe\nEach ampoule/vial/prefilled syringe to contain\n250IU of Antitetanus Immunoglobulin obtained\nfrom Human Plasma containing specific anti\nbodies against Clostridium tetani suitable for\nintramuscular or intravenous injection.\nNote:\n1.This injection should be stable for 24 months\nwhen stored within a temperture range of 2'C-8'C.\nDo not freeze.\n2.The manufacturer should submit a certificate for\neach batch of the product that it has been tested\nfree of Hepatitis B,Hepatitis C and HIV infections.\n3.Each ampoule/vial/prefilled syringe should be\nlabelled accordingly. etc .
Supply of Medicine and Medical / Surgical equipments : Dried Recombinant Factor VIII Fraction 200IU-\n350IU vial\nDried Recombinant Factor VIII Fraction 200IU-\n350IU vial\nDried factor VIII Fraction BP (Dried Recombinant\nAntihaemophilic Fraction) 200IU-350IU vial\nOR\nRecombinant Coagulation Factor VIII Ph Eur.\n200IU-350IU vial\nOR\nRecombinant Antihemophilic Factor USP 200IU-\n350IU vial\nOR\nDried Recombinant Antihaemophilic Fraction\nIP200IU-350IU vial\nEach vial to contain 200IU-350IU of concentrated,\npurified and viruses inactivated 3rd or 4th\ngeneration recombinant dried factor VIII Fraction\nBP, Ph Eur, USP or IP.\nNote:\n1. The item should be stable at temperature 2oC –\n8oC.\n2. The product should have minimum 24 months\nshelf life at the time of delivery to MSD.\n3. Tenderer should submit detailed specifications\nof the product offered.\n4. The product should ensure, at least two steps on\nvirus inactivation as recommended by\nWHO/US.FDA\n5. The purification process should be specified by\nthe manufacturer.\n6. Each batch should be certified as free from HIV\nhepatitis and other viruses.\n7. Anti viral test methods used for screening for\nHIV and Hepatitis viruses should be declared by\nthe manufacturer. The test methods used should\nbe approved by WHO/US.FDA.\n8. Each vial to be supplied with suitable diluent.\n9. The product should be protected from light. etc .
Tenders by Country